BioSpace News Archive

Nu-Med Plus, Inc., a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, announced that the United States Patent and Trademark Office has issued US patent #10682486 for a single-use or short-term use nitric oxide inhaler.

Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it will report its financial results for the second quarter ended June 30, 2020, on Thursday, August 6, before the market opens. Menlo will host a conference call and webcast at 8:30 a.m. Eastern Time to discuss the fin

Goethe University, University Hospital Frankfurt and miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that preliminary results from a Phase 1 trial detailing the pharmacodynamic activity of MRG-110 has been published in the peer-reviewed journal Nucleic Acid Therapeutics . “We are pleased to have the

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, plans to report second quarter 2020 financial results on Thursday, August 6, 2020, after the close of U.S. markets. Following the announcement, the company will host a conference call beginning at 5:30 p.m. ET to

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it can now provide broader access to its growing inventory of plasma, serum and saliva specimens from active and recovered COVID-19 patients for use in drug, diagnostic and vaccine research.

Nascent Biotech, Inc. (OTCQB:NBIO), announced today it has entered into a research collaboration with Syracuse University to further the development of Pritumumab, a unique monoclonal antibody that binds to cell-surface vimentin, for potential use in COVID-19 treatment.

SignPost Cancer Dx Inc., a company developing an advanced molecular diagnostic test to identify invasive breast cancer, is pleased to announce the filing of a provisional patent for the companys lead diagnostic test - BreastDefense. SignPost

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces the appointment of Hoi-Bun “Benson” Suen as Vice President of International Sales.

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2020 results after the market close on Tuesday, August 11, 2020.

Thermo Scientific Gemini Analyzer with LowDoseID for narcotics analysis eliminates concentration limitations from testing process